Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors

Author： Schmitt Christian   Dietrich Sascha   Ho Antony   Witzens-Harig Mathias  

Publisher： Springer Publishing Company

ISSN： 0939-5555

Source： Annals of Hematology, Vol.91, Iss.3, 2012-03, pp. : 391-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin

By Biehn Suzanne   Moore Dominic   Voorhees Peter   Garcia Reynaldo   Lehman Mary   Dees E.   Orlowski Robert  

Annals of Hematology, Vol. 86, Iss. 3, 2007-03 ,pp. : 211-216

Springer Publishing Company

Access to resources Recommend Favorite

Immunogenicity of Influenza Vaccination in Patients with Non-Hodgkin Lymphoma

By Centkowski Piotr   Brydak Lidia   MachaŁa Magdalena   Kalinka-Warzocha Ewa   BŁAsiŃSka-Morawiec Maria   Federowicz Irena   Walewski Jan   Wc{E}? Joanna   WoŁOwiec Dariusz   Lech-MaraŃDa Ewa   Sawczuk-Chabin Joanna   BiliŃSki PrzemysŁAw   Warzocha Krzysztof  

Journal of Clinical Immunology, Vol. 27, Iss. 3, 2007-05 ,pp. : 339-346

Springer Publishing Company

Access to resources Recommend Favorite

Significance of clinical factors as prognostic indicators for patients with peripheral Tcell nonHodgkin lymphoma: A retrospective analysis of 252 cases

By                          

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 911-917

Spandidos Publications

Access to resources Recommend Favorite

Analysis of clinical characteristics, diagnosis, treatment and prognosis of 46 patients with primary gastrointestinal nonHodgkin lymphoma

By          

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 259-264

Spandidos Publications

Access to resources Recommend Favorite

Bendamustine for non-Hodgkin lymphoma

By Gribben John  

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 123-125

Informa Healthcare

Access to resources Recommend Favorite